Alligator Bioscience
0.264
SEK
-0.94 %
ATORX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
3 following
-0.94%
-49.91%
-80.03%
-77.44%
-61.68%
-62.92%
-81.22%
-95.13%
-98.7%
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Read moreMarket cap
200.77M SEK
Turnover
473.31K SEK
Revenue
58.11M
EBIT %
-428.46 %
P/E
-
Dividend yield-%
-
Financial calendar
13/2
2025
Annual report '24
24/4
2025
Interim report Q1'25
ShowingAll content types
Alligator Bioscience AB meddelar utfall för nyttjandet av teckningsoptioner serie TO 9
Sista dag för handel med teckningsoptioner serie TO 9 i Alligator Bioscience AB är den 13 december 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools